Alkem Laboratories CFO Nitin Agrawal resigns, last day 30 September 2026

Cfo ResignedManagement Changes View source PDF Explain this filing

ALKEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.9%Reaction day

₹5413.00

prior close

₹5329.50

announcement price

In-mkt

timing

Nifty Midcap 150market-2.0%+0.1% vs market

Pharmaceuticals peers, median of 172sector-1.0%-0.9% vs sector

On the reaction day the stock moved 0.1 pts more than Nifty Midcap 150 and 0.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.2

10m

-0.1

15m

-0.6

30m

-0.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.9-2.0+0.1-1.0-0.9

Next day

-2.6-2.1-0.4-0.8-1.8

-4.4-3.7-0.7-1.8-2.6

-3.0-4.7+1.7-1.4-1.7

-4.6-4.6+0.0-2.5-2.1

-3.6-5.6+2.0-3.0-0.6

-2.8-4.1+1.3-2.8-0.0

15d

-6.7-5.2-1.5-5.6-1.1

-7.1-9.2+2.2-9.7+2.6

—————

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Alkem Laboratories CFO Nitin Agrawal has resigned to pursue new professional opportunities. He submitted his resignation on 30 July 2026 and will continue in a senior management role until 30 September 2026. During his tenure he led several strategic initiatives including building the MedTech business, acquisitions of Adroit and Bombay Ortho, creation of Alkem Wellness, and the Saudi joint venture.

Likely market impact

CFO exit at a major pharma firm; investors will track successor appointment and continuity of key strategic projects.